Adjunctive bright light in non-seasonal major depression: Results from patient-reported symptom and well-being scales

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Adjunctive bright light in non-seasonal major depression : Results from patient-reported symptom and well-being scales. / Martiny, Klaus; Lunde, M.; Undén, M.; Dam, H.; Bech, P.

I: Acta Psychiatrica Scandinavica, Bind 111, Nr. 6, 01.06.2005, s. 453-459.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Martiny, K, Lunde, M, Undén, M, Dam, H & Bech, P 2005, 'Adjunctive bright light in non-seasonal major depression: Results from patient-reported symptom and well-being scales', Acta Psychiatrica Scandinavica, bind 111, nr. 6, s. 453-459. https://doi.org/10.1111/j.1600-0447.2005.00532.x

APA

Martiny, K., Lunde, M., Undén, M., Dam, H., & Bech, P. (2005). Adjunctive bright light in non-seasonal major depression: Results from patient-reported symptom and well-being scales. Acta Psychiatrica Scandinavica, 111(6), 453-459. https://doi.org/10.1111/j.1600-0447.2005.00532.x

Vancouver

Martiny K, Lunde M, Undén M, Dam H, Bech P. Adjunctive bright light in non-seasonal major depression: Results from patient-reported symptom and well-being scales. Acta Psychiatrica Scandinavica. 2005 jun. 1;111(6):453-459. https://doi.org/10.1111/j.1600-0447.2005.00532.x

Author

Martiny, Klaus ; Lunde, M. ; Undén, M. ; Dam, H. ; Bech, P. / Adjunctive bright light in non-seasonal major depression : Results from patient-reported symptom and well-being scales. I: Acta Psychiatrica Scandinavica. 2005 ; Bind 111, Nr. 6. s. 453-459.

Bibtex

@article{1509193b72f548ccb0b0b916cb443b7c,
title = "Adjunctive bright light in non-seasonal major depression: Results from patient-reported symptom and well-being scales",
abstract = "Objective: In this study, we tested the efficacy of bright light therapy as an adjunct to antidepressant treatment (sertraline) in patients with non-seasonal major depression. Method: In a randomized double-blind controlled trial, 102 patients were treated for 5 weeks with either white bright light (10.000 lx, 1 h/day) or red dim light (50 lx, 30 min/day). All patients received sertraline in a dosage of 50 mg daily. The self-assessment scales used were the Major Depression Inventory (MDI), the Psychological General Well-Being Scale (PGWB) and the Symptom Check List (SCL-90R). Results: On all three questionnaires the score differences between baseline and endpoint were greatest in the bright light group. On the SCL-90R, the difference reached statistical significance. Results and effect sizes are compared with results from Danish national population studies applying PGWB and SCL-90R. Conclusion: The results advocate the use of bright light as an adjunct treatment of non-seasonal depression.",
keywords = "Cross-sectional studies, Light, Melancholia, Phototherapy, Randomized controlled trial, Seasonal depression, Self-assessment",
author = "Klaus Martiny and M. Lunde and M. Und{\'e}n and H. Dam and P. Bech",
year = "2005",
month = jun,
day = "1",
doi = "10.1111/j.1600-0447.2005.00532.x",
language = "English",
volume = "111",
pages = "453--459",
journal = "Acta Psychiatrica Scandinavica. Supplementum",
issn = "0065-1591",
publisher = "Wiley-Blackwell Publishing,",
number = "6",

}

RIS

TY - JOUR

T1 - Adjunctive bright light in non-seasonal major depression

T2 - Results from patient-reported symptom and well-being scales

AU - Martiny, Klaus

AU - Lunde, M.

AU - Undén, M.

AU - Dam, H.

AU - Bech, P.

PY - 2005/6/1

Y1 - 2005/6/1

N2 - Objective: In this study, we tested the efficacy of bright light therapy as an adjunct to antidepressant treatment (sertraline) in patients with non-seasonal major depression. Method: In a randomized double-blind controlled trial, 102 patients were treated for 5 weeks with either white bright light (10.000 lx, 1 h/day) or red dim light (50 lx, 30 min/day). All patients received sertraline in a dosage of 50 mg daily. The self-assessment scales used were the Major Depression Inventory (MDI), the Psychological General Well-Being Scale (PGWB) and the Symptom Check List (SCL-90R). Results: On all three questionnaires the score differences between baseline and endpoint were greatest in the bright light group. On the SCL-90R, the difference reached statistical significance. Results and effect sizes are compared with results from Danish national population studies applying PGWB and SCL-90R. Conclusion: The results advocate the use of bright light as an adjunct treatment of non-seasonal depression.

AB - Objective: In this study, we tested the efficacy of bright light therapy as an adjunct to antidepressant treatment (sertraline) in patients with non-seasonal major depression. Method: In a randomized double-blind controlled trial, 102 patients were treated for 5 weeks with either white bright light (10.000 lx, 1 h/day) or red dim light (50 lx, 30 min/day). All patients received sertraline in a dosage of 50 mg daily. The self-assessment scales used were the Major Depression Inventory (MDI), the Psychological General Well-Being Scale (PGWB) and the Symptom Check List (SCL-90R). Results: On all three questionnaires the score differences between baseline and endpoint were greatest in the bright light group. On the SCL-90R, the difference reached statistical significance. Results and effect sizes are compared with results from Danish national population studies applying PGWB and SCL-90R. Conclusion: The results advocate the use of bright light as an adjunct treatment of non-seasonal depression.

KW - Cross-sectional studies

KW - Light

KW - Melancholia

KW - Phototherapy

KW - Randomized controlled trial

KW - Seasonal depression

KW - Self-assessment

U2 - 10.1111/j.1600-0447.2005.00532.x

DO - 10.1111/j.1600-0447.2005.00532.x

M3 - Journal article

C2 - 15877712

AN - SCOPUS:20144375210

VL - 111

SP - 453

EP - 459

JO - Acta Psychiatrica Scandinavica. Supplementum

JF - Acta Psychiatrica Scandinavica. Supplementum

SN - 0065-1591

IS - 6

ER -

ID: 209243856